dc.contributor.author | Yaqoob, K | en_US |
dc.contributor.author | Naderi, H | en_US |
dc.contributor.author | Thomson, R | en_US |
dc.contributor.author | Aksentijevic, D | en_US |
dc.contributor.author | Petersen, S | en_US |
dc.contributor.author | Aung, N | en_US |
dc.contributor.author | Yaqoob, M | en_US |
dc.date.accessioned | 2023-06-27T09:01:40Z | |
dc.date.issued | 2023-06-14 | en_US |
dc.identifier.issn | 0931-0509 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/89242 | |
dc.publisher | Oxford University Press (OUP) | en_US |
dc.relation.ispartof | Nephrology Dialysis Transplantation | en_US |
dc.subject | Cardiovascular | en_US |
dc.subject | Heart Disease | en_US |
dc.subject | Kidney Disease | en_US |
dc.subject | Clinical Research | en_US |
dc.subject | Cardiovascular | en_US |
dc.subject | Renal and urogenital | en_US |
dc.subject | 3 Good Health and Well Being | en_US |
dc.title | #4703 IMPACT OF THE EARLY STAGES OF CKD WITH AND WITHOUT PROTEINURIA ON CARDIOVASCULAR OUTCOMES IN THE UK BIOBANK COHORT | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1093/ndt/gfad063c_4703 | en_US |
pubs.issue | Supplement_1 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 38 | en_US |
qmul.funder | Immunometabolic cross-talk in the inflamed diabetic heart::Wellcome Trust | en_US |
qmul.funder | Immunometabolic cross-talk in the inflamed diabetic heart::Wellcome Trust | en_US |
qmul.funder | Immunometabolic cross-talk in the inflamed diabetic heart::Wellcome Trust | en_US |
qmul.funder | Immunometabolic cross-talk in the inflamed diabetic heart::Wellcome Trust | en_US |